Status:
COMPLETED
The Effectiveness of Continuous Ketamine Infusion (KONTINUE)
Lead Sponsor:
Centre Hospitalier Princesse Grace
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Brief Summary
There are different treatment for chronic pain. One possible treatment is intravenous infusions of ketamine.
Detailed Description
Ketamine continuous intravenous infusion for 4 days in Hospital with 0.5 mg/kg/day associated with Magnesium Sulfate 1000mg/day. Evaluation schedules will be performed at day 15,30 and 60.
Eligibility Criteria
Inclusion
- \- Pain lasting for more than six months without contraindication to treatment
Exclusion
- Inability to give consent
- Severe psychiatric disorder
Key Trial Info
Start Date :
February 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 6 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06131970
Start Date
February 22 2022
End Date
August 6 2024
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Princesse Grace
Monaco, Monaco, 98000